FDA advisers recommend against Delcath's cancer therapy
(Reuters) - A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer ...
Read More »(Reuters) - A panel of advisers to the U.S. health regulator unanimously recommended against approving Delcath Systems Inc's cancer ...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Programs that attempt to encourage or force hospital doctors to cut back on prescrib...
Read More »By Trevor Stokes NEW YORK (Reuters Health) - Emergency helicopter transport is expensive, but could become cost effective if it's us...
Read More »
By Genevra Pittman NEW YORK (Reuters Health) - Practicing with lighter baseballs may help teen pitchers improve their throwing speed...
Read More »By Toni Clarke (Reuters) - An advisory panel to the Food and Drug Administration recommended that the agency reject a kidney cancer ...
Read More »
By Caroline Humer NEW YORK (Reuters) - The nation's largest health insurers are far from leaping at the chance to join new state hea...
Read More »
By Genevra Pittman NEW YORK (Reuters Health) - Close to two-thirds of women favor making contraceptive pills available over the coun...
Read More »
By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - Human cases of a deadly new strain of bird flu that has killed ...
Read More »By Ransdell Pierson and Bill Berkrot (Reuters) - Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combin...
Read More »DUBAI (Reuters) - Saudi Arabia said five more people have died of a deadly new virus from the same family as SARS, and two other peo...
Read More »